Colchicine is not an NSAID. Despite being used for some of the same conditions, colchicine belongs to a completely different drug class and works through a distinct biological mechanism. It is classified as an alkaloid, originally extracted from the bulbs of a plant called Colchicum autumnale (meadow saffron). Understanding why it’s different from NSAIDs matters, because the two types of drugs carry different risks, interact with different medications, and are sometimes even used together.
How Colchicine Works Differently From NSAIDs
NSAIDs like ibuprofen and naproxen reduce inflammation by blocking enzymes called cyclooxygenases (COX enzymes). These enzymes produce chemicals that trigger pain, swelling, and fever. Block the enzymes, and you dial down those symptoms.
Colchicine does not touch COX enzymes at all. Instead, it binds to a protein called tubulin, which is a building block of tiny internal scaffolding structures inside your cells called microtubules. When colchicine locks onto tubulin, it prevents these structures from assembling properly. That disruption interferes with the ability of white blood cells to migrate toward the site of inflammation, a process called chemotaxis. Fewer inflammatory cells arriving at the scene means less swelling, pain, and tissue damage. It’s a fundamentally different approach: NSAIDs block the chemical signals of inflammation, while colchicine physically prevents immune cells from showing up in the first place.
Why the Confusion Exists
Colchicine and NSAIDs overlap in one high-profile condition: gout. Both are first-line options for treating acute gout flares, which is why many people assume they belong to the same drug family. The American College of Rheumatology even lists colchicine and NSAIDs side by side as treatment choices for gout flares, and doctors sometimes prescribe low-dose colchicine alongside an NSAID as prophylaxis while starting long-term urate-lowering therapy. That pairing only works because they act through separate pathways and can complement each other.
Another source of confusion is that both drugs are oral anti-inflammatory medications taken as pills. But “anti-inflammatory” is a description of what a drug does, not a drug class. Corticosteroids are also anti-inflammatory, and nobody confuses them with ibuprofen.
What Colchicine Is Approved to Treat
The FDA has approved colchicine for two main uses: treating and preventing acute gout flares (taken at the first sign of a flare) and managing Familial Mediterranean Fever in patients aged four and older. Gout flares happen when uric acid crystals accumulate in a joint and trigger an intense inflammatory response. Colchicine works particularly well here because it targets the specific type of white blood cell activity that crystal deposits provoke.
Beyond these approved uses, colchicine has gained significant attention for cardiovascular protection. A Cochrane review covering 12 studies and nearly 23,000 patients found high-certainty evidence that low-dose colchicine reduces the risk of heart attack and stroke in people with established cardiovascular disease, without increasing serious adverse events. The benefit emerged in patients who took it for at least six months as secondary prevention. It did not, however, reduce the risk of dying from cardiovascular causes or the need for procedures to reopen blocked arteries. This cardiovascular application is one of the reasons colchicine has moved well beyond being seen as “just a gout drug.”
Narrow Therapeutic Window
One of the most important practical differences between colchicine and NSAIDs is how little room there is between a helpful dose and a dangerous one. Colchicine has a narrow therapeutic index, meaning the concentration that works and the concentration that causes toxicity are uncomfortably close. Effective blood levels range from roughly 0.5 to 3 micrograms per liter, and toxic effects can begin right around 3 micrograms per liter.
For an acute gout flare, the FDA-approved dosing is 1.2 mg at the first sign of symptoms, followed by 0.6 mg one hour later. That’s it for the first day. Older dosing regimens that had patients taking colchicine every hour or two until side effects appeared have been abandoned because they were genuinely dangerous.
Colchicine toxicity unfolds in phases. In the first 10 to 24 hours, nausea, vomiting, abdominal pain, and diarrhea are typical. Over the next several days, more serious complications can develop, including bone marrow suppression, organ failure, and cardiac problems. Even at therapeutic doses, gastrointestinal side effects like diarrhea and nausea are the most common complaints, though they tend to be mild and short-lived.
Drug Interactions to Be Aware Of
Colchicine is processed in the body through two pathways (CYP3A4 and P-glycoprotein) that many other common medications also use. When another drug blocks both of these pathways simultaneously, colchicine levels in the blood can skyrocket. In one study, the antifungal ketoconazole increased colchicine exposure by an average of 212%, with one participant seeing a 420% increase. The immune-suppressing drug cyclosporine raised it by 259% on average, and the antiviral ritonavir pushed it up by 296%, with one person experiencing a ninefold increase.
Heart medications are a particular concern. Diltiazem and verapamil, both commonly prescribed for blood pressure and heart rhythm, roughly doubled colchicine exposure in healthy volunteers. Amiodarone, another heart rhythm drug, is also expected to raise levels based on its known effects on the same pathways. These interactions can cause life-threatening toxicity, including severe bone marrow suppression, organ failure, and dangerous heart rhythms. If you take any of these medications, your doctor will likely need to adjust your colchicine dose or choose an alternative.
NSAIDs, by contrast, carry their own set of interaction risks (primarily with blood thinners, blood pressure medications, and kidney function), but they don’t share this specific vulnerability. This is another reason the distinction between the two drug classes matters in practice.
Colchicine vs. NSAIDs at a Glance
- Drug class: Colchicine is a plant-derived alkaloid. NSAIDs are a broad class of synthetic anti-inflammatory drugs.
- Mechanism: Colchicine disrupts white blood cell migration by interfering with microtubules. NSAIDs block COX enzymes that produce inflammatory chemicals.
- Overlap: Both treat gout flares and reduce inflammation, but through entirely separate pathways.
- Dosing sensitivity: Colchicine has a narrow therapeutic window where small dose changes matter significantly. Most NSAIDs have a wider margin of safety at standard doses.
- Common side effects: Colchicine most often causes diarrhea and nausea. NSAIDs are best known for stomach irritation, ulcer risk, and effects on kidney function.
- Unique to colchicine: Proven benefit in cardiovascular disease prevention and treatment of Familial Mediterranean Fever.